Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: PolyPeptide Group AG

Market Cap 1.21B 1.4B 1.12B 1.04B 1.95B 133B 1.99B 13.25B 5.14B 64.51B 5.25B 5.14B 224B P/E Ratio 2026 *
72.7x
P/E Ratio 2027 * 31.2x
Enterprise Value 1.32B 1.52B 1.21B 1.14B 2.12B 145B 2.17B 14.42B 5.59B 70.17B 5.71B 5.59B 244B EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.45x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.08%
1 day+1.78%
1 week-9.15%
Current month-9.63%
1 month-12.18%
3 months+39.80%
6 months+39.51%
Current year+31.23%
1 week 33.5
Extreme 33.5
37.75
1 month 33.5
Extreme 33.5
39.6
Current year 23.1
Extreme 23.1
41.7
1 year 19.62
Extreme 19.62
41.7
3 years 13.22
Extreme 13.22
41.7
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
23-11-12Buy 2,500 0.0075%
23-10-11Buy 159,959 0.4829%
23-04-05Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+1.78%-9.15%+59.30%+47.12% 1.4B
+0.11%+1.50%+41.25%+156.48% 1,013B
+0.84%+5.44%+54.95%+50.46% 574B
+0.13%+0.46%+18.00%+64.07% 397B
-0.18%+4.97%+21.24%+15.95% 324B
+0.89%+0.35%+24.72%+14.98% 280B
+2.11%+4.97%+25.36%+33.86% 273B
+2.00%-0.73%+17.57%+57.83% 182B
-0.13%-1.59%-45.94%-48.93% 194B
+3.55%-5.50%+11.69%+56.79% 151B
Average +1.07%+1.47%+22.81%+44.86% 339B
Weighted average by Cap. +0.66%+3.99%+28.72%+71.17%

Financials

2026 *2027 *
Net sales 480M 555M 443M 414M 773M 52.85B 790M 5.26B 2.04B 25.59B 2.08B 2.04B 89B 550M 635M 507M 474M 885M 60.54B 905M 6.02B 2.34B 29.32B 2.39B 2.33B 102B
Net income 16.51M 19.08M 15.22M 14.24M 26.58M 1.82B 27.17M 181M 70.14M 880M 71.62M 70.08M 3.06B 41.1M 47.49M 37.89M 35.45M 66.14M 4.52B 67.63M 450M 175M 2.19B 178M 174M 7.62B
Net Debt 106M 123M 97.98M 91.67M 171M 11.7B 175M 1.16B 451M 5.67B 461M 451M 19.7B 137M 158M 126M 118M 220M 15.07B 225M 1.5B 582M 7.3B 594M 581M 25.38B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
26-06-11 34.45 CHF +1.92% 14,213
26-06-10 33.80 CHF -4.25% 49,115
26-06-09 35.30 CHF -2.08% 25,589
26-06-08 36.05 CHF -0.96% 60,540
26-06-05 36.40 CHF -3.45% 52,676
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
36.66EUR
Average target price
39.11EUR
Spread / Average Target
+6.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!